Cite

HARVARD Citation

    Haake, A. et al. (2020). An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease. Expert opinion on drug safety. 19 (2), pp. 147-157. [Online]. 
  
Back to record